Hépato-Gastro & Oncologie Digestive


How to apply the treat-to-target concept during ulcerative colitis Volume 25, supplement 3, Novembre 2018


  • Figure 1


1 CHU Rennes,
Service des maladies de l’appareil digestif,
2 rue Henri le Guillou,
35033 Rennes cedex, France
2 Université de Rennes,
Institut NUMECAN (Nutrition Metabolisms and Cancer),
F-35000 Rennes, France
* Tirés à part

The treat to target strategy has gradually been developed during Crohn's disease. This concept is based on regular assessment of disease activity by using objective clinical and biological outcome measures and the subsequent adjustment of treatments, complementary to the concept of early intervention in high-risk patients. These changes in the therapeutic management of Crohn's disease are the consequences of the failure of strategies based on symptoms, unable to prevent disease complication and disability related to disease. Crohn's disease and ulcerative colitis both belong to the inflammatory bowel disease group that usually leads to compare and gather concepts and managements between each disease. The concept of treat-to-target may be partly applied for UC, but physicians need to be aware of some specificities in the follow-up of this disease.

Licence This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License